Cargando…

MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis

BACKGROUND AND AIMS: The nature and outcomes of infection among patients with cirrhosis in safety-net hospitals are not well described. We aimed to characterize the rate of and risk factors for infection, both present on admission and nosocomial, in this unique population. We hypothesized that infec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fricker, Zachary P., Mukthinuthalapati, V. V. Pavan Kedar, Akinyeye, Samuel, Chalasani, Naga, Attar, Bashar M., Balakrishnan, Maya, Ghabril, Marwan, Long, Michelle T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222109/ https://www.ncbi.nlm.nih.gov/pubmed/32100160 http://dx.doi.org/10.1007/s10620-020-06164-y

Ejemplares similares

Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2019)

Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis
por: Patidar, Kavish R., et al.
Publicado: (2019)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

Duodenorenal Fistula after Microwave Ablation Presenting as Melena
por: Mukthinuthalapati, V.V. Pavan Kedar, et al.
Publicado: (2018)

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
por: Orman, Eric S., et al.
Publicado: (2019)

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level
por: Chetwood, John D., et al.
Publicado: (2022)

Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2022)

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
por: Ngwa, Taiwo, et al.
Publicado: (2020)

Thin Patient, Fatty Liver
por: Mukthinuthalapati, V V Pavan Kedar, et al.
Publicado: (2019)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2023)

Incorporation of frailty estimated by gait speed within MELD-Na and the predictive potential for mortality in cirrhosis
por: Deng, You, et al.
Publicado: (2020)

Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018
por: Nephew, Lauren D., et al.
Publicado: (2023)

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis
por: Cheng, Xiang-Pu, et al.
Publicado: (2016)

Effectiveness of the MELD/Na Score and the Child–Pugh Score for the Identification of Palliative Care Needs in Patients with Cirrhosis of the Liver
por: Puentes, Juan Carlos Perdomo, et al.
Publicado: (2018)

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease
por: Coppel, Scott, et al.
Publicado: (2020)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
por: Coxeter-Smith, Catherine, et al.
Publicado: (2023)

The MELD-Plus: A generalizable prediction risk score in cirrhosis
por: Kartoun, Uri, et al.
Publicado: (2017)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

Sex disparities in waitlisting and liver transplant for acute liver failure
por: Nephew, Lauren D., et al.
Publicado: (2020)

4295 The Impact of Social Determinants of Health on Hepatocellular Carcinoma Outcomes
por: Nephew, Lauren Devore, et al.
Publicado: (2020)

Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders
por: Desai, Archita P., et al.
Publicado: (2021)

Outcomes of Acute Respiratory Distress Syndrome in Mechanically Ventilated Patients With Cirrhosis
por: Boente, Ryan D., et al.
Publicado: (2019)

Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score
por: Kaiser, Thorsten, et al.
Publicado: (2017)

Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation
por: Lee, Hannah, et al.
Publicado: (2017)

Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis
por: Behroozian, Ramin, et al.
Publicado: (2012)

MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome
por: Silberhumer, Gerd R., et al.
Publicado: (2023)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States
por: Nephew, Lauren D., et al.
Publicado: (2020)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study
por: Nephew, Lauren D., et al.
Publicado: (2023)

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL
por: de FREITAS, Alexandre Coutinho Teixeira, et al.
Publicado: (2016)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
por: Kang, Seong Hee, et al.
Publicado: (2018)

Comparison of lymphocyte-to-monocyte ratio with Child-Pugh and PELD/MELD scores to predict the outcome of children with cirrhosis
por: Salehi, Alireza, et al.
Publicado: (2021)

Prognostic Role of MELD-Lactate in Cirrhotic Patients' Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis
por: Chen, Xiao-Fu
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffv782dfufbcnkefhacle89q5v